Accumulation of99mTc-HM-PAO in photon deficient areas in bone scan of bone metastasis from hepatocellular carcinoma

[1]  S. Hashimoto,et al.  [Tumor imaging using 99mTc-hexamethylpropyleneamine oxime]. , 1990, Kaku igaku. The Japanese journal of nuclear medicine.

[2]  H. Hoshi,et al.  Tc-99m Hexamethylpropylene-amine Oxine (HM-PAO) Uptake in a Bone Metastasis , 1988, Clinical nuclear medicine.

[3]  R. Hellman,et al.  Photon deficient bone metastasis of hepatocellular carcinoma with avid gallium-67 uptake. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  C. Golimbu,et al.  Hepatocellular carcinoma with skeletal metastasis. , 1985, Radiology.

[5]  T. Tomomitsu,et al.  A Case of Synovial Sarcoma with Bone Metastasis Identified by Bone Marrow Scintigraphy , 1984, Kaku igaku. The Japanese journal of nuclear medicine.

[6]  A. le Pape,et al.  Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Potsaid,et al.  Accuracy of 99mTC-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases. , 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.

[8]  H. Faunce,et al.  Significance of absent or faint kidney sign on bone scan. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Henkin,et al.  False negative bone scans in disseminated metastatic disease. , 1974, Radiology.

[10]  H. Fleisch,et al.  Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo , 1969, Science.